Love, R. (2021). By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Archives of Breast Cancer, 8-13. https://doi.org/10.32768/abc.2021818-13